STM
Journals
—
Open Access
Special Issue
Topic

Cancer Immunotherapy

Guest Editor:

        • Abstract Submission Deadline : 30/11/2023

        Manuscript Submission Deadline : 25/12/2023

        [This article belongs to Special Issue Cancer Immunotherapy under section ijonnp, ijonnp in (ijonnp, ijonnp)]

        Special Issue Description

        Immunotherapy is a form of cancer treatment that makes use of the patient’s immune system. Immunotherapy can alter or enhance the immune system’s functioning to help it identify and combat cancer cells. Knowing how immunotherapy works and what to anticipate can frequently help you be ready for treatment and make knowledgeable decisions about your care if your treatment plan includes it. Monoclonal antibodies, Checkpoint Inhibitors. Checkpoint inhibitors, Cytokines, Vaccines to treat cancer, CAR T-cell therapy, etc. are the various types of cancer immunotherapy. Lowered blood counts brought on by immunotherapy may result in bleeding, anemia, and other issues. Lungs. Immune checkpoint inhibitors have the potential to result in pneumonitis, an inflammation of the lungs that can lead to a cough or breathing difficulties. Although uncommon, pneumonitis can be dangerous. In this special issue, we are inviting you to submit your research work focused on medical oncology, cell culture, gene therapy, and immunotherapy for the international journal of oncological Nursing.

        Editor Keywords

        CAR T-cell
        Cytokines
        Checkpoint inhibitors
        Inflammation
        Cancer

        Manuscript Submission information

        Manuscripts should be submitted online by registering and logging in to this link. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed.
        Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent on email address:[email protected] for announcement on this website.

        Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page.

        Participating journals:

        Journal Name

        International Journal of Oncological Nursing and Practices, International Journal of Oncological Nursing and Practices

        Abbrivation

        ijonnp, ijonnp

        ISSN

        Since

        APC

          $